|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003933,
umls-concept:C0009015,
umls-concept:C0017262,
umls-concept:C0017337,
umls-concept:C0022209,
umls-concept:C0026926,
umls-concept:C0185117,
umls-concept:C0205217,
umls-concept:C0317761,
umls-concept:C0683598,
umls-concept:C1274040,
umls-concept:C1880022,
umls-concept:C2911684
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-3-22
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Arylamine N-acetyltransferases (NATs) are found in many eukaryotic organisms, including humans, and have previously been identified in the prokaryote Salmonella typhimurium. NATs from many sources acetylate the antitubercular drug isoniazid and so inactivate it. nat genes were cloned from Mycobacterium smegmatis and Mycobacterium tuberculosis, and expressed in Escherichia coli and M. smegmatis. The induced M. smegmatis NAT catalyzes the acetylation of isoniazid. A monospecific antiserum raised against pure NAT from S. typhimurium recognizes NAT from M. smegmatis and cross-reacts with recombinant NAT from M. tuberculosis. Overexpression of mycobacterial nat genes in E. coli results in predominantly insoluble recombinant protein; however, with M. smegmatis as the host using the vector pACE-1, NAT proteins from M. tuberculosis and M. smegmatis are soluble. M. smegmatis transformants induced to express the M. tuberculosis nat gene in culture demonstrated a threefold higher resistance to isoniazid. We propose that NAT in mycobacteria could have a role in acetylating, and hence inactivating, isoniazid.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-1329759,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-1569093,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-1581193,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-1968463,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-2082148,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-2340091,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-2860675,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-5851956,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-7598738,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-7600914,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-7717963,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-7773298,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8220441,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8320241,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8425184,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8466547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8537659,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8655566,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8861781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-8960058,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9170149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9173883,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9245815,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9278503,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9364141,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9417034,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-950592,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9535705,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9973365-9634230
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0021-9193
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
181
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1343-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9973365-Amino Acid Sequence,
pubmed-meshheading:9973365-Antitubercular Agents,
pubmed-meshheading:9973365-Arylamine N-Acetyltransferase,
pubmed-meshheading:9973365-Cloning, Molecular,
pubmed-meshheading:9973365-Drug Resistance, Microbial,
pubmed-meshheading:9973365-Enzyme Induction,
pubmed-meshheading:9973365-Escherichia coli,
pubmed-meshheading:9973365-Genes, Bacterial,
pubmed-meshheading:9973365-Genetic Vectors,
pubmed-meshheading:9973365-Isoniazid,
pubmed-meshheading:9973365-Microbial Sensitivity Tests,
pubmed-meshheading:9973365-Molecular Sequence Data,
pubmed-meshheading:9973365-Mycobacterium smegmatis,
pubmed-meshheading:9973365-Mycobacterium tuberculosis,
pubmed-meshheading:9973365-Sequence Homology, Amino Acid
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
|
|
pubmed:affiliation |
Department of Pharmacology, University of Oxford, Oxford OX1 3QT, United Kingdom.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
